Healthcare -
Drug Manufacturers - General - NYSE - US
$ 171.56
-1.23 %
$ 303 B
Market Cap
59.99
P/E
ABBV - COST OF REVENUE
Cost of Revenue ABBV - AbbVie Inc.
20.4 B
LAST VALUE
8.17%
2 YEAR CAGR
21.48%
5 YEAR CAGR
16.12%
10 YEAR CAGR